CHARLOTTE MOSS: Open Payments
NPI 1700338704 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 32 payments from 9 companies in 2025. Trend: 2023 $371 · 2024 $826 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $126 |
| Genmab U.S., Inc. | 5 | $122 |
| Eisai Inc. | 4 | $104 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| ABBVIE INC. | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Caris MPI, Inc. | 3 | $56 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: Lenvima, JEMPERLI, ELAHERE, LYNPARZA, KEYTRUDA, Tivdak, MI CANCER SEEK, ENHERTU.
Industry payments across MS — which companies pay providers there.
